Novasep to supply API to Celladon; FDA OKs Kemwell plant; Recipharm and Adroit work together;

> Novasep and Celladon have an API supply agreement for Novasep to manufacture Celladon's genetically targeted enzyme replacement therapy MYDICAR. Release

> Horizon Discovery Group has received £652,000 from the U.K.'s Advanced Manufacturing Supply Chain Initiative to expand bioproduction research into how to accelerate the development of novel and improved Chinese hamster ovary cell lines. Report

> Bangalore, India-based CDMO Kemwell says it has successfully passed an FDA inspection tied to an ANDA submitted by a client. Release

> CDMO Recipharm will begin using solid state characterization services from Adroit Science. Release

And Finally... A compounders group is discouraging members from providing drugs for state executions. Story

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.